Carcinoma, Hepatocellular/genetics; Gene Expression Regulation, Neoplastic; Hepatitis B/genetics; Liver Neoplasms/genetics; Neoplasms, Second Primary/genetics; Proteins/genetics; RNA, Small Interfering/genetics; Adult; Carcinoma, Hepatocellular/complications; Carcinoma, Hepatocellular/pathology; Carcinoma, Hepatocellular/virology; Cell Cycle Proteins/genetics; Cell Cycle Proteins/metabolism; Cell Line, Tumor; Female; G1 Phase Cell Cycle Checkpoints; Hepatitis B/complications; Hepatitis B/pathology; Hepatitis B/virology; Hepatitis B Surface Antigens/genetics; Hepatitis B Surface Antigens/metabolism; Hepatitis B e Antigens/genetics; Hepatitis B e Antigens/metabolism; Hepatitis B virus/physiology; Humans; Liver Neoplasms/complications; Liver Neoplasms/pathology; Liver Neoplasms/virology; Male; Middle Aged; Neoplasms, Second Primary/complications; Neoplasms, Second Primary/pathology; Neoplasms, Second Primary/virology; Proteins/antagonists & inhibitors; Proteins/metabolism; RNA, Small Interfering/metabolism

RNA interference; carboxypeptidase D; cell cycle; hepatoma; therapeutic target